In a cell line model of human urothelial carcinoma, EP4R antagonists decreased cancer cell migration and viability, and enhanced the effects of a commonly used chemotherapeutic, cisplatin, implying the potential role of EP4R antagonists in the treatment of several human malignancies [44]. Here, PTGER4 is linked to cancer.